An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Clinical trial NCT02869789 · COMPLETED
Trial details
- NCT number
- NCT02869789
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-05
- Primary completion
- 2022-05-13
- Enrollment
- 1041
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.